Structural Heart Intervention
TE’s engineering expertise in minimally invasive technologies spans across valvular, congenital and structural diseases. Our development teams are partners of choice for structural heart intervention device innovation.
Open heart surgery was traditionally the treatment for patients suffering from structural heart disease, until Dr. Alain Cribier pioneered the first TAVR procedure in 2002. Shortly afterwards, we co-created a steerable large bore shaft for the delivery of a TAVR valve, evolving the face of structural heart therapy. TE plays a leading role in providing comprehensive structural heart device solutions that enables LAA occlusion device delivery, PFO closure, protection device deployment and aortic valvuloplasty. TE has expertise not only in access, delivery and closure but additionally, is advancing sensor-based smart catheter solutions, including IVUS, ICE and OCT, essential tools used in the diagnosis and treatment of structural heart patients.
Device Solutions
- Large bore shafts (14F - 24F)
- Composite laminate shafts
- Pull wires and collar assemblies
- Deployment handles
- Guidewires
- High precision BAV catheter
- 0.035" shaped guidewire
- Transseptal needle and access sheath
Technical Expertise
- Hybrid & combination sheath constructions
- Integration of pull wires & pull wire lumens into delivery shaft wall
- Precision 1-way, 2-way and multi-steering
- Multi durometer shafts/jacket
- Outer shaft valve retrieval mechanisms
- High-strength pull wire mechanisms and connections
- Fluoropolymer engineering and marker band optimization
- Torque converter coils and ‘lock & key’ shaft connection systems
- Steering & deflection
- Expandable solutions
e
e
e
e
e
e
